Ying, J., Xu, Q., Li, J., Wei, Q., Zhang, L., Zhou, S., Zheng, M., Yang, Y. (2025). First-line serplulimab and bevacizumab combined with nab-paclitaxel/gemcitabine followed by mFOLFOX in advanced pancreatic cancer: A phase II trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.4162